Related Experiment Video
Updated: Apr 5, 2026
08:30
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
13.8K
Neuroinflammation in Glaucoma and Optic Nerve Damage
Caitlin E Mac Nair1, Robert W Nickells2
1Ophthalmology and Visual Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA; Cellular and Molecular Pathology Graduate Program, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Progress in Molecular Biology and Translational Science
|August 28, 2015
Summary
Glaucoma involves the degeneration of retinal cells, leading to blindness. This review explores how neuroinflammation and glial cell activation in the eye contribute to glaucoma pathogenesis.
Area of Science:
- Ophthalmology
- Neuroscience
- Immunology
Background:
- Glaucoma is a leading cause of irreversible blindness worldwide.
- Current treatments for glaucoma are limited and often minimally effective.
- Neuroinflammation involving innate immune cells in the eye is increasingly implicated in glaucoma.
Purpose of the Study:
- To discuss normal glial function in the healthy eye.
- To explore the role of glial activation in glaucomatous neurodegeneration.
- To understand the contribution of neuroinflammation to optic nerve and retinal damage.
Main Methods:
- Review of mechanisms of glial function in ocular health.
- Analysis of glial activation pathways in glaucoma.
- Examination of neuroinflammatory processes in the optic nerve and retina.
Main Results:
- Glia, the resident immune cells of the eye, play a critical role in maintaining ocular health.
- Dysregulation and activation of glia contribute significantly to the neurodegenerative processes in glaucoma.
- Neuroinflammation is a key factor driving retinal ganglion cell damage.
Conclusions:
- Understanding glial cell behavior and neuroinflammation is crucial for developing effective glaucoma therapies.
- Targeting glial activation presents a potential therapeutic strategy for glaucoma.
- Further research into ocular neuroinflammation may unlock new treatment avenues for preventing blindness.
Keywords:
AstrocytesGlaucomaImmune privilegeMicrogliaMüller cellsNeuroinflammationRetinal ganglion cellsMore Related Videos
Related Concept Videos
01:25Glaucoma: Overview
1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
01:28Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K